Tokyo: Life Sciences and Health Care Horizons 2019
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
12 September 2019
12 September 2019
25 April 2019
Japan is the latest country to pass a new law, “the Act regarding the Promotion of Use of Sea Areas to Develop Offshore Renewable Energy Facilities" (Saiene Kaiiki Riyou Hou), to ...
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
Tokyo: 28 Nov 2018, Osaka: 26 Nov 2018
Cross-practice, multi-track seminar on advanced trademark issues, global M&A transactions, global patent updates for technology companies, energy investments, and recent...